ECSP034616A - NEW DERIVATIVES OF PIRAZOLOPIRIDINA SUBSTITUTED WITH PIRIDINE - Google Patents

NEW DERIVATIVES OF PIRAZOLOPIRIDINA SUBSTITUTED WITH PIRIDINE

Info

Publication number
ECSP034616A
ECSP034616A EC2003004616A ECSP034616A ECSP034616A EC SP034616 A ECSP034616 A EC SP034616A EC 2003004616 A EC2003004616 A EC 2003004616A EC SP034616 A ECSP034616 A EC SP034616A EC SP034616 A ECSP034616 A EC SP034616A
Authority
EC
Ecuador
Prior art keywords
pirazolopiridina
piridine
substituted
new derivatives
designates
Prior art date
Application number
EC2003004616A
Other languages
Spanish (es)
Inventor
Johannes Peter Stasch
Stefan Weigand
Elisabeth Perzborn
Elke Stahl
Alexander Straub
Dieter Lang
Klaus Dembowsky
Achim Feurer
Alija Cristina Alonso
Dietmar Flubacher
Frank Wunder
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of ECSP034616A publication Critical patent/ECSP034616A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

En la que R1 designa 4-piridina o 3 piridinilo R2 designa H. NH2 o halógeno, así como sales isomeros e hidratos de los mismos como estimulantes de la guanilatociclasa soluble y para el uso como agentes para el tratamiento de enfermedades cardiocirculatorias, hipertonia, trastornos tromboembolicos e isquemias disfunción sexual o inflamaciones así como para el tratamiento de enfermedades del sistema nervioso central.In which R1 designates 4-pyridine or 3 pyridinyl R2 designates H. NH2 or halogen, as well as isomeric salts and hydrates thereof as stimulants of soluble guanylate cyclase and for use as agents for the treatment of cardiocirculatory diseases, hypertonia, disorders thromboembolic and ischemia sexual dysfunction or inflammation as well as for the treatment of diseases of the central nervous system.

EC2003004616A 2000-11-22 2003-05-21 NEW DERIVATIVES OF PIRAZOLOPIRIDINA SUBSTITUTED WITH PIRIDINE ECSP034616A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10057753 2000-11-22

Publications (1)

Publication Number Publication Date
ECSP034616A true ECSP034616A (en) 2003-06-25

Family

ID=7664122

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2003004616A ECSP034616A (en) 2000-11-22 2003-05-21 NEW DERIVATIVES OF PIRAZOLOPIRIDINA SUBSTITUTED WITH PIRIDINE

Country Status (12)

Country Link
KR (1) KR20030065519A (en)
DE (2) DE10131987A1 (en)
DO (1) DOP2001000291A (en)
EC (1) ECSP034616A (en)
GT (1) GT200100235A (en)
HN (1) HN2001000261A (en)
MY (1) MY127212A (en)
PE (1) PE20020581A1 (en)
RU (1) RU2003118584A (en)
SV (1) SV2003000743A (en)
UA (1) UA74404C2 (en)
ZA (1) ZA200303887B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102485724B (en) * 2010-12-06 2015-08-12 中国人民解放军军事医学科学院毒物药物研究所 Substituted thiophene base pyrazolo-pyridines and medicinal use thereof
UA120278C2 (en) 2011-11-25 2019-11-11 Адверіо Фарма Гмбх SUBSTITUTED 5-FLUORINE-1H-PYRAZOLOPYRIDINES IN CRYSTAL FORM
JP7101688B2 (en) * 2016-10-11 2022-07-15 バイエル・ファルマ・アクティエンゲゼルシャフト Combinations containing sGC stimulants and mineral corticoid receptor antagonists

Also Published As

Publication number Publication date
DOP2001000291A (en) 2002-12-15
RU2003118584A (en) 2004-12-20
DE10131987A1 (en) 2002-05-23
HN2001000261A (en) 2002-01-30
DE50106655D1 (en) 2005-08-04
SV2003000743A (en) 2003-01-13
MY127212A (en) 2006-11-30
KR20030065519A (en) 2003-08-06
PE20020581A1 (en) 2002-07-13
UA74404C2 (en) 2005-12-15
ZA200303887B (en) 2004-06-21
GT200100235A (en) 2002-06-25

Similar Documents

Publication Publication Date Title
AR031176A1 (en) NEW DERIVATIVES OF PIRAZOLPIRIDINA SUBSTITUTED WITH PIRIDINE
ECSP045081A (en) DERIVATIVES OF 1,8-NAFTIRIDINE AND ITS USE FOR THE TREATMENT OF DIABETES AND RELATED DISORDERS
SV2002000022A (en) MONOAMIDE RECANALIZATION INHIBITORS FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS REF. PC10434
PA8442201A1 (en) 6-PHENYLPIRIDYL-2-AMINE DERIVATIVES
GT199900150A (en) 1,2,3,4-TETRAHYDROQUINOLINS 2-SUBSTITUTED 4-CARBOXYAMIN SUBSTITUTED.
ES2132223T3 (en) INDOL DERIVATIVES CONDENSED AS ANTAGONISTS OF THE 5-HT4 RECEPTOR.
MXPA04004370A (en) Polycyclic guanine derivative phosphodiesterase v inhibitors.
UY28150A1 (en) THERAPEUTIC AGENTS
BR9911575A (en) 4-benzyl piperidine alkyl sulfoxide heterocyclics and their use as selective subtype nmda receptor antagonists
CR7042A (en) INDANIL ACILATED AMINAS AND ITS USE AS PHARMACOS
DK1578740T3 (en) 1,2,4-triaminobenzene derivatives suitable for the treatment of central nervous system disorders
UY27055A1 (en) GLUCOQUINASA FUSIONED HETEROAROMATIC ACTIVATORS
CL2004000655A1 (en) COMPOUNDS DERIVED FROM PIPERIDIN-2-ONA 1,6-DISUSTITUTED, ITS SALTS, PHARMACEUTICAL COMPOSITION, AGONISTS OF THE EP4 RECEIVER; USE OF COMPOUNDS TO TREAT OCULAR HYPERTENSION, GLAUCOMA.
ES2156287T3 (en) DERIVATIVES OF DIFENILMETILEN PIPERIDINA.
MX9700429A (en) Use of thiazole and thiadiazole compounds as d3 dopamine receptor ligands.
ECSP045473A (en) DERIVATIVES OF 1- (AMINOALQUIL) -3-SULFONYLINDOL AND 1-AMINOALQUIL-3-SULFONYLINDAZOL AS 5-HYDROXYTHYRIPTAMINE-6 LIGANDS
AR028705A1 (en) BIS-ARILSULPHONES
DE60020595D1 (en) 3,4-DIHYDRO- (1H) CHINAZOLIN-2-ON COMPOUNDS AS CSBP / P38 KINASE INHIBITORS
PA8527401A1 (en) 7-OXO-PYRIDOPIRIMIDINAS (II)
IT1282673B1 (en) CAMPTOTECIN DERIVATIVES AND THEIR USE AS ANTI-CANCER AGENTS
ATE302776T1 (en) CONDENSED PYRIDOINDOLE DERIVATIVES
ATE281439T1 (en) 3,4-DIHYDRO-(1H)CHINAZOLINE-2-ONE COMPOUNDS AS CSBP/P38 KINASE INHIBITORS
UY27998A1 (en) HETEROCYCLIC REPLACED SUBSTITUTED PIPERAZINES FOR THE TREATMENT OF CHICHOPHRENIA
AR029588A1 (en) NEW FORM (R) -N- [5-METHYL-8- (4-METHYLIPIPERAZINE-1-IL) -1,2,3,4-TETRAHYDRO-2-NAFTIL] -4-MORFOLINOBENZAMIDA
ES2196069T3 (en) MORFINOID DERIVATIVES CONDENSED WITH HETEROCICLES.